Tuesday, June 21, 2022

NINR Extramural Program: News, Updates, and Opportunities

June Newsletter

Having trouble viewing this email? View it as a Web page.

Logo_GovD

June 2022

NINR Extramural Program: News, Updates, and Opportunities


Grants

This monthly newsletter for NINR applicants and awardees provides useful information about funding initiatives and other opportunities.


An Outage Alert for Grantees Currently Preparing Progress Reports

A technical update to Research Performance Progress Report (RPPR) forms is scheduled for June 23, 2022. If your award is not eligible for the Streamlined Noncompeting Award Process (SNAP) and your RPPR budget form is in progress but not submitted, you will lose any saved progress when the update takes place.

Thus, we advise non-SNAP grantees with in-progress RPPRs to complete and submit the forms before June 22 or wait until after June 23 to begin filling out the forms. See eRA Alert: Action Required for In-Progress RPPR Budget Forms Due to RPPR Update June 23; Updated RPPR Instruction Guide Available for more details.

Funding Opportunities

The NIH Guide recently published the following funding opportunity announcements (FOAs):

New Funding Opportunities

  • RFA-ES-22-003: Research Coordinating Center for the Climate Change and Health Community of Practice (U24 – Clinical Trial Not Allowed) solicits applications from eligible institutions to develop a Research Coordinating Center to support the development of an NIH Climate Change and Health (CCH) initiative Community of Practice (COP) by managing and supporting current CCH research and capacity building efforts, and supporting the expansion of the COP in the long term. Application Due Date: August 25, 2022
  • NOT-ES-22-006: Notice of Special Interest (NOSI): Climate Change and Health encourages applications that address the impact of climate change on health and well-being over the life course, including the health implications of climate change in the United States and globally. First Available Due Date: July 8, 2022
  • NOT-ES-22-009 and NOT-ES-22-010: NOSI: Innovative Technologies for Research on Climate Change and Human Health supports research to develop or adapt practical technologies for capturing the effects of climate change and extreme weather events on human health and to reduce the health threats posed by climate change across the lifespan. 
    • NOT-ES-22-009: Small Business Technology Transfer (STTR), R41/R42 Clinical Trial Optional. First Available Due Date: September 5, 2022
    • NOT-ES-22-010: Small Business Innovation Research (SBIR), R43/R44 Clinical Trial Optional. First Available Due Date: September 5, 2022
  • NOT-PM-22-002: NOSI: Administrative Supplements to Advance Precision Medicine Using the All of Us Research Program's Data encourages eligible grantees of the participating Institutes, Centers, and Offices to apply for administrative supplements to support analysis of currently available data within the All of Us Research Program's Researcher Workbench or to develop analysis tools for the available data within the general scope of the parent award. First Available Due Date:  July 5, 2022

  • PAR-22-105 and PAR-22-109: Dissemination and Implementation Research in Health supports studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies.
    • PAR-22-105R01 Clinical Trial Optional. Next Application Due Date: October 05, 2022
    • PAR-22-109R21 Clinical Trial Optional. Next Application Due Date: October 16, 2022
  • NOT-OD-22-106: NOSI: Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan encourages applications proposing to test multilevel strategies and interventions to improve the uptake of evidence-based screening services across the lifespan and in populations including, but not limited to, those experiencing health disparities and those that are underserved. Multiple application due dates; check NOSI for due dates by specific submission funding opportunity announcement.
  • NOT-OD-22-107: NOSI: Addressing Evidence Gaps in Screening solicits applications proposing to strengthen the evidence base for preventive screening services where the evidence is lacking, of poor quality, conflicting, or the balance of benefits and harms cannot be determined. Multiple application due dates; check NOSI for due dates by specific submission funding opportunity announcement.
  • NOT-NS-22-087: NOSI: Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain will support supplements to existing HEAL clinical research awards to allow exceptional graduate, post-doctoral, or early career individuals to expand their clinical pain research experience and gain access to the tools and skills needed to prepare them for a career in clinical pain research. Next Application Due Date: February 15, 2023
  • PA-22-176: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) invites eligible United States small businesses to submit SBIR grant applications that do not propose a clinical trial. First Application Due Date: September 05, 2022
  • PA-22-177: PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) invites eligible United States small businesses to submit SBIR grant applications that propose at least one clinical trial. First Application Due Date: September 05, 2022
  • PA-22-178 and PA-22-179: PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications invites eligible United States small businesses to submit STTR grant applications.
    • PA-22-178Parent STTR [R41/R42] Clinical Trial Not Allowed. First Application Due Date: September 05, 2022
    • PA-22-179Parent STTR [R41/R42] Clinical Trial Required. First Application Due Date: September 05, 2022
  • NOT-OD-22-141: NOSI: Administrative Supplements to NIH-funded T32 and TL1 Training Grants to Better Integrate Behavioral and Social Sciences with other Health-Related Sciences solicits applications for a one-time administrative supplement to existing NIH T32 and TL1 training grants for the enhancement of activities that support the acquisition of expertise and skills that are foundational to conducting multidisciplinary science that integrates behavioral and social sciences with biomedical approaches, methods, paradigms, and outcomes. Application Due Date: July 11, 2022

NINR News and Events

NINR Director's Lecture Series

2022 NINR Director's Lecture Series: Social Determinants of Health

Join NINR on July 12, 2022 from 10:00-11:00 a.m. (ET) as we bring leading experts in social determinants of health to share their knowledge at the first NINR Director's Lecture of 2022. Dr. Vincent Guilamo-Ramos, Dean of the School of Nursing at Duke University, and Dr. Brian Castrucci, President and CEO of de Beaumont Foundation, will be presenting research priorities and the practice and policy implications of nursing research through the social determinants of health lens. Learn More and Register

 

NINR 2022–2026 Strategic Plan

NINR 2022–2026 Strategic Plan

NINR is excited to launch our 2022–2026 Strategic Plan which outlines our vision for supporting science that advances our mission: to lead nursing research to solve pressing health challenges and inform practice and policy—optimizing health and advancing health equity into the future. Learn More

 


This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute of Nursing Research National Institutes of Health · 31 Center Drive, Room 5B10 · Bethesda, MD 20892-2178 GovDelivery logo

No comments:

Post a Comment

What’s Holding You Back From Learning More?

Join my free 5-day course to explore dividend investing. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ...